Elevance Health reported mixed second-quarter results with adjusted EPS of $7.45 beating estimates, but down 15.7% year-over-year, and a 1.5% decline in medical membership. Operating revenues grew slightly to $49.8 billion, driven by its CarelonRx division. Despite challenges, the company raised its full-year 2026 adjusted EPS forecast to at least $27.00 and increased its operating cash flow outlook after reaching $6.2 billion in Q2. RBC Capital lowered its price target to $424, still implying an 8.63% upside from the current stock price of $390.33.
T3 Defense Inc. will execute a 1-for-125 reverse stock split on July 20, 2026, combining every 125 shares into one to increase its share price. This move aims to raise the stock price from its current low of $0.05 per share and comply with NASDAQ lis...
General Electric, now operating as GE Aerospace, reported strong Q2 2026 earnings with EPS of $2.02 and revenue of $13.35 billion, both exceeding analyst expectations. The company's growth was driven by high demand in its commercial aerospace service...
Heilind Electronics announced the availability of the Brady i4311 Industrial Label Printer, a portable, cordless printer that combines benchtop-quality wide-format printing with all-day battery life and ergonomic design. Weighing 13 lbs and capable o...
The American Kidney Fund (AKF) has launched a new online course on lupus nephritis through its Kidney Health Coach program. This initiative aims to educate both community members and healthcare professionals about the symptoms, testing, diagnosis, tr...
UnitedHealth Group reported strong Q2 earnings per share of $6.38, surpassing analyst estimates of around $4.90. Revenue also exceeded expectations at $112.03 billion, showing continued growth from last year. Following the results, the company raised...
